Selected article for: "liver disease and physical activity"

Author: O'Gorman, Philip; Norris, Suzanne
Title: Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
  • Cord-id: 127ls79u
  • Document date: 2021_6_24
  • ID: 127ls79u
    Snippet: COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to sup
    Document: COVID-19 is a major public health pandemic. Risk factors for severe infection and poorer outcomes include cardiovascular disease, obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). Lifestyle interventions, including diet and physical activity modifications, are the current recommended treatment for NAFLD. In this communication, the authors discuss the crossover link between NAFLD and severe COVID-19 infection and the impact of essential public health measures to suppress the spread of COVID-19 on exercise and physical activity participation in patients with NAFLD. The future of exercise prescription and the potential use of digital technology in addressing NAFLD healthcare needs in the COVID-19 era are also explored.

    Search related documents:
    Co phrase search for related documents
    • abnormal liver function and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abnormal liver function and liver obesity: 1
    • abnormal liver function and long discharge: 1
    • abnormal liver function test and liver disease: 1, 2
    • abnormal liver function test and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • adipokine release and liver obesity: 1
    • adipose tissue and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • adipose tissue and liver function: 1, 2, 3
    • adipose tissue and liver obesity: 1, 2, 3, 4, 5, 6, 7, 8
    • adipose tissue and liver obesity disease: 1, 2, 3
    • liver function and long discharge: 1